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Abstract
Background: Descending inhibitory pain control contributes to the endogenous defense against chronic pain and
involves noradrenergic and serotonergic systems. The clinical efficacy of antidepressants suggests that serotonin
may be particularly relevant for neuropathic pain conditions. Serotonergic signaling is regulated by synthesis,
metabolisms, reuptake and receptors.
Results: To address the complexity, we used inbred mouse strains, C57BL/6J, 129 Sv, DBA/2J and Balb/c, which
differ in brain serotonin levels. Serotonin analysis after nerve injury revealed inter-strain differences in the
adaptation of descending serotonergic fibers. Upregulation of spinal cord and midbrain serotonin was apparent
only in 129 Sv mice and was associated with attenuated nerve injury evoked hyperalgesia and allodynia in this
strain. The increase of dorsal horn serotonin was blocked by hemisectioning of descending fibers but not by
rhizotomy of primary afferents indicating a midbrain source. Para-chlorophenylalanine-mediated serotonin
depletion in spinal cord and midbrain intensified pain hypersensitivity in the nerve injury model. In contrast,
chronic inflammation of the hindpaw did not evoke equivalent changes in serotonin levels in the spinal cord and
midbrain and nociceptive thresholds dropped in a parallel manner in all strains.
Conclusion: The results suggest that chronic nerve injury evoked hypernociception may be contributed by genetic
differences of descending serotonergic inhibitory control.
Background
The development of chronic pain is essentially contribu-
ted by loss of inhibitory control of nociceptive signaling
mediated by GABAergic or glycinergic interneurons
[1-3] and descending inhibitory serotonergic or noradre-
nergic neurons which originate in the midbrain [4-7].
Pharmacological strengthening of the descending inhibi-
tory pain pathway is thought to contribute to analgesic
effects of antidepressants and the opioid agonist trama-
dol [7,8] suggesting that this inhibitory pathway is clini-
cally relevant particularly for neuropathic pain which in
animal models, is associated with profound and long-
lasting changes in gene expression [9,10] including those
of neuronal tryptophan hydroxylase [11].
In the brain, serotonin is produced by neuronal tryp-
tophan hydroxylase Tph2 [12] which also accounts for
serotonin synthesis in dorsal root ganglia [11] and is
localized within a nociceptive quantitative trait locus
[13]. We hypothesized that adaptations of Tph2-
mediated serotonin synthesis may impact on the efficacy
of the descending serotonergic pain control and may
contribute to the variability of nociception. However,
serotonin plays a multifaceted role in nociceptive excita-
tory and inhibitory signaling [4,14] and is not only con-
trolled by the rate of its production but also
metabolism, reuptake and receptor distribution. There-
fore, instead of using a specific deletion model we chose
four inbred strains, C57BL/6J, 129 Sv, DBA/2J and Balb/
c to assess the in vivo relevance of serotonergic pain
control within the context of complex phenotypes. The
selection of the strains was based on preliminary screen-
ing results which showed differences in brain serotonin
levels in these strains, being largely in agreement with
data previously found in the striatum of various mouse
strains [15] and concentrations in various brain regions
in C57Bl/6J mice [16].
Previous studies have revealed that inflammatory pain
is strongly controlled by glycinergic inhibition [17]
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which however does not impact on nerve injury or for-
malin evoked hypersensitivity [18]. Conversely, nerve
injury was associated with GABAergic dysinhibition
[1,19]. Hence, depending on the stimulus, inhibitory
pain control may involve different in part overlapping or
interacting inhibitory circuits. Based on previous studies
we hypothesized a strong serotonergic influence on
nerve injury evoked hypernociception [20-23]. To
address the presumed complexity we assessed nocicep-
tion in models of chronic inflammatory and neuropathic
pain, as well as the formalin assay. In parallel, we ana-
lyzed serotonin concentrations assuming that the
amount of serotonin at various sites of the brain and
spinal cord was best to reflect the availability and turn-
over of the neurotransmitter.
Methods
Animals
Male C57BL/6J, 129 Sv, DBA/2J, and BALB/c mice
(Charles River, Sulzfed, Germany), 8-12 weeks old, were
housed three to four per cage at constant room tem-
perature (21 ± 1°C) and relative humidity (60%) under a
regular light/dark schedule (light on from 7:00 A.M. to
7:00 P.M.) with freely available food and water. Animals
were allowed to adapt to laboratory conditions and habi-
tuate to the test cages for at least 1 week before starting
an experiment with the measurement of baseline noci-
ceptive behavior. Procedures were conducted in confor-
mity with the institutional, national and European laws
and policies for animal research and adhered to guide-
lines set out by the International Association for the
Study of Pain (IASP) for the research of pain in con-
scious animals. They were approved by the local Ethic
Committee for Animal Research (Darmstadt, Germany).
In situ hybridization
Total RNA was extracted from mouse DRG tissue and
reversely transcribed with random primers. The frag-
ment was cloned into the pCR4-TOPO plasmid vector
(Invitrogen) and sequenced. Riboprobes were obtained
by in vitro transcription and labeling with digoxigenin
(Dig-labeling kit, Roche).
Fresh frozen DRGs were cut at 14 μm, fixed for 10
min in 4% paraformaldehyde in 0.1 M PBS and acety-
lated. Sections were prehybridized for 2 h at RT and
hybridized at 70°C for 16 h with 200 ng/ml of sense and
antisense probes in the prehybridization mix (50% for-
mamide, 5 × SSC, 5 × Denhardt’s solution, 500 μg/ml
herring sperm DNA, 250 μg/ml yeast tRNA) [11],
washed in 0.2% SSC at 60°C and incubated with anti-
Dig-AP (1:1000 Roche) in 0.12 M maleic acid buffer
with 0.15 M NaCl, pH 7.5 and 1% Blocking Reagent
(Roche), washed in TBS, equilibrated in alkaline buffer
(0.1 M Tris-HCl, 0.1 M NaCl, 0.05 M MgCl2, pH 9.5, 2
mM levamisole) and developed with NBT/BCIP AP sub-
strate (Roche Diagnostics). Slides were embedded in gly-
cerol/gelatin. Images were obtained using an Eclipse
E600 fluorescence microscope equipped with a Kappa
DX 20 H camera and Kappa ImageBase software.
Immunofluorescence
Mice were intracardially perfused with 0.9% saline fol-
lowed by 4% paraformaldehyde in 0.1 M phosphate buf-
fered saline (PBS, pH 7.4) under terminal isoflurane
anesthesia. The L4-5 spinal cord (lumbar enlargement)
was removed, postfixed in the same fixative overnight
(4°C), embedded with Tissue-Tek® O.C.T. Compound
(Science Services, Munich, Germany) and 14 μm thick
transversal sections were cut on a cryotome. Sections
were incubated in blocking buffer (1% blocking reagent
(Roche), 0.05% Triton X-100 in 0.1 M PBS) for 1 h at
room temperature and incubated overnight at 4°C with
the primary rabbit polyclonal antibody directed against
cFos (1:500, Santa Cruz Biotechnology), serotonin (1:500
Abcam) or tyrosine hydroxylase (sheep, 1:500, Abcam).
Binding sites were visualized with Cy3 or Alexa-488
conjugated secondary antibodies. Images were obtained
with a Zeiss fluorescence microscope. For quantitative
analysis of cFos we counted cFos immunoreactive neu-
ronal nuclei in the dorsal horn (superficial and deep
layers) of four mice of each strain. Five sections sepa-
rated by 60-80 μm were counted per mouse and the
mean number of cFos IR neurons was used for statisti-
cal comparisons. For quantification of serotonin immu-
noreactivity we used the AutMess Modul of AxioVision
(Zeiss). We analyzed the area of 5-HT IR and mean
density.
Serotonin analysis
The brain, spinal cord and dorsal root ganglia (DRGs)
were rapidly excised and respective brain regions, L4/5
spinal cord and L4/5 DRGs frozen on dry ice and kept
at -80°C until analysis. Serotonin was analyzed by means
of a commercial EIA done as recommended by the
manufacturer (Labor Diagnostika Nord, Nordhorn,
Germany). Serotonin is quantitatively derivatized into
N-acylserotonin and then analyzed in a competition EIA
microtiter format. Samples of 6 mice of each strain were
analyzed for each region.
Behavioral assessment of nociception
Mechanical nociception
We determined the latency of paw withdrawal to a von
Frey-like filament using a Dynamic Plantar Aesthesi-
ometer (Ugo Basile, Comerio, Italy). The steel rod was
pushed towards the plantar paw. The force increases lin-
early over 10 sec from 0-5 grams until a strong and
immediate withdrawal occurs. In case of no withdrawal
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up to 5 gram this maximum force is maintained until
the paw is withdrawn. The withdrawal latency used for
further analysis was the mean of three tests with at least
10 seconds intervals.
Thermal nociception
We recorded the withdrawal latency to heat stimulation
with a Hot Plate at 52°C, cut-off latency 40 s and a time
resolution of 0.1 s (FMI, Föhr Medical Instruments
GmbH, Seeheim/Ober-Beerbach, Germany). To measure
cold sensitivity and cold allodynia, we recorded the
latency for paw withdrawal, licking or jumping after pla-
cing the mice onto a Cold Plate that was kept at 10°C
(AHP-1200CPHC, Teca, Chicago, IL). The withdrawal
latency used for further analysis was the mean of three
tests with at least 3 minutes intervals.
Chemical nociception
We employed the formalin test to assess chemically
evoked acute A-fiber mediated nociception in the first
phase and C-fiber sensitization in the second phase of
the test [24,25]. We injected 20 μl 5% formalin into the
left hindpaw and monitored the licking time for 45 min
in 5 min intervals starting directly after injection of the
irritant into the paw. The time the mouse spent licking
the paw during the first and second phases of the test
was used for statistical comparisons.
Nerve injury and chronic inflammatory models
Surgery and injections of Complete Freud’s Adjuvant
(CFA) were carried out under 2% isoflurane anesthesia.
For the spared nerve injury (SNI) model of neuropathic
pain, two of the three peripheral branches of the sciatic
nerve, the common peroneal and the tibial nerves, were
ligated with silk (6-0) and distally transected, leaving the
sural nerve intact [26,27]. We measured nociceptive
behavior (mechanical and cold withdrawal latencies)
before and 2-3 times weekly after the nerve injury up to
3 weeks after SNI.
For rhizotomy, we transected the L4 and L5 dorsal
roots. The dorsal funiculus was transected at the distal
thoracic spinal cord by shallow dorsolateral incision.
For the chronic inflammatory model we injected 20 μl
CFA into the plantar side of the left hind paw. Mechani-
cal and heat withdrawal latencies were recorded before
and several times after CFA up to 1 week after the
injection. Eight mice per group were analyzed in each
model.
Serotonin depletion in midbrain and spinal cord
4-Chloro-DL-phenylalanine methyl ester hydrochloride
(pCPA) was used to deplete serotonin. pCPA (0.4 μg/g/
h diluted in Ringer solution) was administered by con-
tinuous intrathecal delivery through a spinal catheter
with a subcutaneously implanted osmotic pump (Alzet
model 2002 for 2 weeks). The control group received
vehicle. Eight mice were used per group. In order to
enable intrathecal delivery, a polytetrafluoroethylene
catheter (PTFE Sub-Lite Wall Tubing 0.05 mm ID ×
0.15 mm OD; Braintree Scientific Inc., USA) was stereo-
tactically inserted after distal hemilaminectomy of verte-
bra L4-L5 under isoflurane anesthesia. The tip of the
catheter was slid in rostral direction and positioned
above the cervical spinal cord to achieve serotonin
depletion in spinal cord and brain areas surrounding the
4th ventricle. The intrathecal catheter was attached to a
silicone tube, which was connected to the outlet of the
Alzet mini-pump. The Alzet pump was inserted into the
subcutaneous space at the left flank. Correct positioning
of the catheter tip was checked at the end of the treat-
ment period by microscopic inspection. The efficacy of
serotonin depletion was confirmed by serotonin immu-
nostainings of lumbar spinal cord sections.
Statistics
Data are presented as means ± s.e.m. unless indicated
differently. Because of differences in baseline withdrawal
thresholds which have been described in detail pre-
viously [28,29] we used the relative change of nocicep-
tive thresholds for statistical comparisons. Areas under
the curves (“%-change” × “time”) were calculated
according to the linear trapezoidal rule and subsequently
compared by analyses of variances (one-way ANOVA)
and post hoc t-tests using a Bonferroni alpha correction.
For quantitative analyses of immunostainings we used
the AutMess modul of AxioVision software (Zeiss). Ser-
otonin concentrations and counts of c-Fos immunoreac-
tive neurons were also compared with one-way ANOVA
and subsequent Bonferroni post hoc analyses, with alpha
< 0.05 for all tests.
Results
Serotonin concentrations in DRGs and spinal cord
To assess expression and adaptation of serotonin in
nociceptive pathways we analyzed dorsal root ganglia
(DRGs), spinal cord and midbrain in naïve mice and
after nerve injury and inflammation. The expression of
Tph2 in the dorsal root ganglia (DRGs) increased after
peripheral nerve injury of the sciatic nerve in the Spared
Nerve Injury model (SNI) in C57Bl/6 mice (Figure 1a).
We did not detect Tph1 in the DRGs. The induction of
Tph2 was associated with an increase of DRG serotonin
concentrations (Figure 1b) in C57BL/6J and Balb/c mice
but not in DBA/2J and 129 Sv mice.
At baseline Balb/c mice showed more serotonin
immunoreactive fibers in the dorsal horn of the spinal
cord as compared to the other strains (Figure 1c, d, e)
and higher serotonin concentrations as determined by
immunoassays (Figure 1f, g). Sciatic nerve injury evoked
a strong increase of dorsal horn serotonin immunoreac-
tivity in 129 Sv mice but not in the other strains
(Figure 1d, e). The quantitative immunoassay analysis of
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Figure 1 Regulation of serotonin production in the spinal cord in inbred mouse strains after sciatic nerve injury. A In situ hybridization
of Tph2 in DRGs on the side ipsilateral and contralateral to a sciatic nerve lesion 7 days after SNI in C57BL/6 mice. Scale bar 50 μm. B Serotonin
concentrations in DRGs of C57BL/6J, 129 Sv, DBA/2J and Balb/c mice from naïve mice and 7 days after SNI (ipsi lateral L4/5 DRGs). Data are the
means ± s.e.m of 4 independent experiments and triplicate analyses. For each experiment pooled tissue from each 3 mice was used. C57BL/6J
mice showed a significant increase after SNI. Asterisks indicate statistically significant differences between strains, with P < 0.05.
C-D Immunofluorescent analysis of serotonin in the L4/5 dorsal horn of the spinal cord of naïve mice and seven days after SNI on the side
ipsilateral to the sciatic nerve lesion. Scale bar: 50 μm. E Pixel analysis of serotonin immunoreactivity (IR) in the dorsal horn of naïve mice and 7
days after SNI of n = 3 mice per group. Of each mouse 2-3 images were analyzed. F Serotonin concentrations in the ipsilateral L4/5 spinal cord
dorsal horn and midbrain (region of nucleus raphe magnus) of C57BL/6J, 129 Sv, DBA/2J and Balb/c mice from naïve mice and 7 days after SNI.
G Serotonin concentrations in the ipsilateral L4/5 spinal cord dorsal horn 21 days after SNI and 7 days after CFA injection into the hindpaw.
Concentrations in F, G are the means ± sem of 4 independent experiments and triplicate analyses. For each experiment pooled tissue from
each 3 mice was used. Asterisks indicate statistically significant differences between strains, with P < 0.05.
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serotonin in ipsilateral dorsal horn tissue supported
these findings (Figure 1f, g). The increase of serotonin
immunoreactivity in 129 Sv mice occurred on both
sides, ispilateral and contralateral of the nerve lesion
(contra not shown). During chronic inflammatory pain
seven days after CFA injection we did not observe sig-
nificant inter-strain differences of serotonin concentra-
tions neither in dorsal horn nor brainstem (Figure 1g).
Baseline differences of serotonin cencentraions in the
dorsal horn were apparently lost during inflammation.
Serotonin immunoreactivity in 129 Sv mice was not
affected by sectioning of the dorsal L4-5 roots (rhizot-
omy, Figure 2a) but disappeared after unilateral section-
ing of the descending dorsal fiber bundles at the distal
thoracic level of the spinal cord (Figure 2a). Serotonin
immunoreactivity was lost completely on the side ipsi-
lateral to the hemisection, and strongly reduced on the
contralateral side suggesting a midbrain source of dorsal
horn serotonin.
Nociception after spinal cord and midbrain depletion
of serotonin
We depleted spinal cord and midbrain serotonin by
intrathecal delivery of para-chlorophenylalanine (pCPA)
and analyzed nociceptive behavior in the SNI model of
neuropathic pain (Figure 2b, c). The localization of the
catheter tip ensured serotonin depletion in the spinal
cord and brain areas surrounding the fourth ventricle.
Serotonin immunoreactivity completely disappeared
after pCPA treatment (not shown). The observed upre-
gulation of serotonin after nerve injury suggested that
the descending serotonergic pain inhibition was relevant
mainly for neuropathic pain. We therefore used the SNI
model to assess the behavioral effect of serotonin deple-
tion. Mice treated with pCPA showed strongly enhanced
mechanical and cold allodynia after SNI as compared to
vehicle treatment (p < 0.05 for both stimuli, comparison
of AUCs) supporting the idea that serotonin contributed
to the endogenous pain control in this model.
Nerve injury evoked neuropathic pain
Based on the observed nerve injury-evoked upregulation
of serotonin in 129 Sv mice we hypothesized that this
may be associated with a relative protection against neu-
ropathic pain in this strain. We used the Spared Nerve
Injury model of neuropathic pain to address this ques-
tion. During the first week after nerve injury all strains
showed a similar drop of the mechanical withdrawal
latency (Figure 3a), suggesting that early adaptations
were similar in all strains. In the second and third week,
withdrawal curves separated (Figure 3a, b). 129 Sv mice
were the least sensitive and DBA/2J showed strongest
mechanical hypersensitivity. The time curves of cold
allodynia revealed immediate inter-strain differences
after nerve injury (Figure 3c). Overall, 129 Sv showed
the least neuropathic pain-like behavior.
Formalin evoked nociception and c-Fos induction
To assess potential inter-strain differences of tonic sero-
tonin-mediated nociceptive inhibition we used the for-
malin test where the behavioral phenomena occur
mainly within the first hour after its injection i.e. before
the onset of transcriptional adaptations. We hypothe-
sized that this test may reflect baseline serotonergic dif-
ferences. C57BL/6J and 129 Sv were the only two lines
in which the typical two-phase response was observed,
i.e strong licking behavior during the first 5 min after
formalin injection, and a second strong licking behavior
between 20 and 40 min, separated by a characteristic
lack phase between 10 and 15 min. The overall response
however, was much stronger in C57BL/6J as compared
to 129 Sv and Balb/c mice (Figure 4a, b). DBA/2J
showed a late second phase and total licking times were
similar to C57BL/6J.
Formalin injection into the hind paw elicits c-Fos upre-
gulation in nociceptive neurons in the dorsal horn of the
spinal cord, which has been shown to be genetically
determined [30]. The number of c-Fos immunoreactive
neurons therefore provides a biochemical indicator for
the strength of nociceptive signaling. Representative
immunostainings are shown in Figure 4c-f, counts of
c-Fos immunoreactive neurons in Figure 4g. In terms of
c-Fos activation, Balb/c mice were less sensitive to forma-
lin than C57BL/6J and DBA/2J mice and similar to 129
Sv. Hence, high baseline serotonin concentrations in the
spinal cord were associated with a weak formalin-evoked
increase of c-Fos immunoreactive neurons.
Chronic inflammatory hyperalgesia
Based on the lack of substantial inter-strain differences
of spinal cord serotonin concentrations during paw
inflammation and loss of baseline differences we
hypothesized that behavioral nociceptive adaptations
may be more alike among strains than those after nerve
injury. As described in detail previously [28,29], heat
pain responses at baseline showed remarkable inter-
strain differences (Figure 5a). However, after injection of
CFA the threshold dropped in a parallel manner in all
strains and inter-strain differences only reappeared in
the very late phase (Figure 5a). The similarity of the
relative change of the threshold was even more obvious
in the dynamic von Frey test for mechanical hypersensi-
tivity (Figure 5c). In the first 8 hours after CFA injec-
tion, there was no significant difference in the relative
decrease of paw withdrawal latencies, neither for ther-
mal nor mechanical stimulation suggesting that the
immediate adaptations were similar in all strains tested.
Comparison of overall AUCs (Figure 5b, d) revealed
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stronger inflammatory hypersensitivity of DBA/2J mice
as compared to the other strains. Peripheral inflamma-
tion itself may follow a genetic program that impacts on
the extent of inflammatory hyperalgesia [31].
Discussion
We observed differences between mouse strains in the
adaptations towards nerve injury-evoked nociception,
whereas during inflammation thresholds shifted downwards
Figure 2 Serotonin afferents in the spinal cord and effects of serotonin depletion. A Immunofluorescent analysis of serotonin in the L4/5
dorsal horn of the spinal cord seven days after sectioning of the dorsal roots L4 and L5 (Rhizotomy) and 7 days after thoracic transection of
descending fibers (dorsolateral corticospinal tract) with tyrosine hydroxylase (TH) counter-staining. Scale bar: 50 μm. The insert shows the
quantitative pixel analysis of 5-HT immunoreactive fibers. B and C Mechanical and cold nociception in the SNI model following depletion of
serotonin in the spinal cord and midbrain. Serotonin depletion was achieved by intrathecal continuous osmotic pump driven infusion of para-
chlorophenylalanine (pCPA), an inhibitor of tryptophan hydroxylases through a spinal i.t. catheter. Control animals received vehicle infusions.
n = 8 per group. Comparison of AUCs revealed that pCPA-mediated serotonin depletion caused a significant aggravation of nociceptive
hypersensitivity after nerve injury.
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in a parallel manner indicating similar adaptations of
inflammatory nociception irrespective of the differences at
baseline. For nerve injury-evoked allodynia and formalin-
evoked nociception inter-strain differences were not pre-
dictable from inter-strain differences of baseline mechanical
or thermal sensitivity, but apparently depended on a geneti-
cally determined adaptation. Comparisons of serotonin
levels in spinal cord and midbrain suggest that the inter-
strain differences of chronic neuropathic pain and formalin-
evoked nociception were partly contributed by differences
in the descending serotonergic inhibitory pain control [32].
129 Sv mice upregulated serotonin in midbrain and spinal
cord after nerve injury and were less sensitive to neuro-
pathic pain compared with the other strains. 129 Sv and
particularly Balb/c had high baseline serotonin in the spinal
cord and midbrain and relatively weaker nociceptive
responses in the second phase of the formalin test
suggesting that serotonin may provide some tonic inhibi-
tory control. In peripheral sensory DRGs neurons serotonin
is supposed to have mainly excitatory functions [33-37] and
may counteract the protective serotonergic effects at spinal
cord synapses. Comparisons of serotonin immunoreactivity
in the dorsal horn after rhizotomy and after sectioning of
descending fiber tracts indicated that the increase of seroto-
nin in the dorsal horn after SNI in 129 Sv mice was mainly
mediated by an increase of serotonin at synapses of des-
cending serotonergic neurons in the dorsal horn. Mostly,
these descending fibers originate from inhibitory neurons in
raphe nuclei of the midbrain and reticular nuclei in the
brainstem [38,39]. The observed intensified neuropathic
pain like behavior in mice depleted of midbrain and spinal
cord serotonin further suggests that the inhibitory pathway
is more relevant for the behavioral manifestation of noci-
ception in mice.
Figure 3 Nociception in the Spared Nerve Injury model of neuropathic pain in four inbred mouse strains. A, C. Time courses and B, D
Box Plots of the areas under the curve (time × percentage change) of paw withdrawal latencies in dynamic von Frey and Cold Plate tests in
C57BL/6J, 129 Sv, DBA/2J and Balb/c mice before and after sciatic nerve injury in the SNI model. Time course data are means ± s.e.m of n = 8 in
each group. Surgery was performed at time “zero” after determination of baseline behavior. Boxes represent the 25th-75th percentile, the line
represents the median, the dashed line the mean, whisker show the 5th-95th percentile. The asterisk indicates statistically significant differences
between strains, with P < 0.05.
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Although largely unexplored, it is likely that inbred
mouse strains differ in further nociception-relevant dif-
ferences of neurotransmitter levels or functions that
may impact on the behavioral response and efficacy of
endogenous inhibitory pain control. Gene expression
profiling has revealed some transcriptional differences
between strains associated with sensitivity to opioids
[40]. Using inbred strains does not allow us to pinpoint
the determinant for the observed differences of brain
serotonin levels. Transcription of neuronal tryptophan
hydroxylase (Tph2) was reported not to differ among
these mouse strains [41,42]. It should be noted however,
Figure 4 Nociception in the formalin tests and c-Fos upregulation in the dorsal horn in four inbred mouse strains. A. Chemical
nociceptive sensitivity of C57BL/6J, 129 Sv, DBA/2J and Balb/c mice. Data are means ± s.e.m of n = 8 in each group. Nociception was assessed
by recording the time course of paw licking behavior after injection of formalin into a hindpaw and B comparison of the total licking times. C-F
Representative results of c-Fos immunoreactivity in the dorsal horn of the spinal cord 2 hours after injection of formalin into the left hindpaw.
c-Fos IR neurons were counted of each four C57BL/6J, 129 Sv, DBA/2J and Balb/c mice. Scale bar: 200 μm. G Quantitative result of c-Fos IR
neurons after formalin injection. The asterisk indicates statistically significant differences between strains, with P < 0.05.
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that a non-synonymous polymorphism of Tph2
(C1473G) was found to determine serotonin production
in the mouse brain [42]. The allelic distribution of this
SNP among the strains however, is not congruent with
brain serotonin levels in the strains. Among the wild
types (C57BL/6J and 129 Sv) one strain has low and one
high levels. The same holds true for the mutants (DBA/
2J and Balb/c). We infer that this SNP, although func-
tional when overexpressed in PC12 cells [42], is not
essentially regulating brain serotonin levels in these
mice. Supporting this conclusion, knock-in mice of this
SNP in a C57BL/6J background did not differ from their
wild type littermates neither in terms of serotonin
synthesis nor behavior [43]. Nonetheless, other func-
tional differences in Tph2, that remain to be identified,
may explain differences of serotonin brain concentra-
tions and the location of Tph2 within one of the pre-
viously reported nociception-QTLs supports the idea
that Tph2-mediated serotonin synthesis is relevant for
nociception. In addition, strain specific serotonin meta-
bolism by monoamine oxidases or serotonin N-acetyl
transferase may account for differences in serotonin
concentrations and behavioral differences, and differ-
ences in the serotonin transporter (Slc6A4) may modu-
late the balance between extracellular and intracellular
serotonin [44].
Experiments with mutant mice lacking a specific sero-
tonin receptor or the serotonin transporter have pre-
viously provided conflicting results in terms of excitatory
and inhibitory functions of serotonin in nociception
[6,7,21,23,33-37,45-47]. Although deletion models are
non-ambiguous on first view, they are confounded by
compensation, background strain and address only one
of the complex modifiers of serotonin pathways. For
example, monoamine oxidase knockout mice loose 5HT-
1A autoreceptors, probably because of the elevated levels
of extracellular serotonin [48], surely confounding inter-
pretation of behavioral results with such mice. Hence,
Figure 5 Inflammatory hyperalgesia in four inbred mouse strains. A, C. Time courses and B, D Box plots of the areas under the curve (time ×
percentage change) of paw withdrawal latencies in Hot Plate and dynamic von Frey tests in C57BL/6J, 129 Sv, DBA/2J and Balb/c mice (data are
means ± s.e.m of n = 8 in each group) before and after injection of Complete Freund Adjuvans into one hindpaw. CFA was injected at time “zero”
after determination of the baseline. Boxes represent the 25th-75th percentile, the line represents the median, the dashed line the mean, whisker
show the 5th-95th percentile. The asterisk indicates statistically significant differences between strains, with P < 0.05.
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the beauty of using inbred mouse strains that differ in the
serotonin levels lies in the clear biochemical phenotype
on the genetic complexity. Hence, our data suggest that
descending serotonergic pain control is genetically deter-
mined and contributes to the strain-specific modulation
of formalin and nerve injury-evoked nociception.
Acknowledgements
The study was supported by the Deutsche Forschungsgemeinschaft (SFB-
815 A12, IT), the Else Kröner Fresenius Foundation (IT), the Heinrich and Fritz
Riese foundation and the NIH (R01 NS058870).
Authors’ contributions
NW carried out immunofluorescent studies, BA performed behavioral
experiments, AH carried out microsurgery and tissue dissection, TM carried
out microscopic slice preparations, LP did behavior experiments, IT
conceived of the study, performed surgery, behavior testing, microscopic
analyses, analyzed data, and wrote the manuscript. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 12 August 2010 Accepted: 26 October 2010
Published: 26 October 2010
References
1. Knabl J, Witschi R, Hosl K, Reinold H, Zeilhofer UB, Ahmadi S, Brockhaus J,
Sergejeva M, Hess A, Brune K, Fritschy JM, Rudolph U, Mohler H,
Zeilhofer HU: Reversal of pathological pain through specific spinal
GABAA receptor subtypes. Nature 2008, 451(7176):330-4.
2. Ahmadi S, Lippross S, Neuhuber WL, Zeilhofer HU: PGE(2) selectively
blocks inhibitory glycinergic neurotransmission onto rat superficial
dorsal horn neurons. Nat Neurosci 2002, 5(1):34-40.
3. Scholz J, Broom DC, Youn DH, Mills CD, Kohno T, Suter MR, Moore KA,
Decosterd I, Coggeshall RE, Woolf CJ: Blocking caspase activity prevents
transsynaptic neuronal apoptosis and the loss of inhibition in lamina II
of the dorsal horn after peripheral nerve injury. J Neurosci 2005,
25(32):7317-23.
4. Suzuki R, Dickenson A: Spinal and supraspinal contributions to central
sensitization in peripheral neuropathy. Neurosignals 2005, 14(4):175-81.
5. Nichols DS, Thorn BE: Stimulation-produced analgesia and its
cross-tolerance between dorsal and ventral PAG loci. Pain 1990,
41(3):347-52.
6. Peng YB, Wu J, Willis WD, Kenshalo DR: GABA(A) and 5-HT(3) receptors
are involved in dorsal root reflexes: possible role in periaqueductal gray
descending inhibition. J Neurophysiol 2001, 86(1):49-58.
7. Zhao ZQ, Chiechio S, Sun YG, Zhang KH, Zhao CS, Scott M, Johnson RL,
Deneris ES, Renner KJ, Gereau RWt, Chen ZF: Mice lacking central
serotonergic neurons show enhanced inflammatory pain and an
impaired analgesic response to antidepressant drugs. J Neurosci 2007,
27(22):6045-53.
8. Berrocoso E, De Benito MD, Mico JA: Role of serotonin 5-HT1A and opioid
receptors in the antiallodynic effect of tramadol in the chronic
constriction injury model of neuropathic pain in rats.
Psychopharmacology (Berl) 2007, 193(1):97-105.
9. Griffin RS, Mills CD, Costigan M, Woolf CJ: Exploiting microarrays to reveal
differential gene expression in the nervous system. Genome Biol 2003,
4(2):105.
10. Woolf CJ, Costigan M: Transcriptional and posttranslational plasticity and
the generation of inflammatory pain. Proc Natl Acad Sci USA 1999,
96(14):7723-30.
11. Tegeder I, Costigan M, Griffin RS, Abele A, Belfer I, Schmidt H, Ehnert C,
Nejim J, Marian C, Scholz J, Wu T, Allchorne A, Diatchenko L, Binshtok AM,
Goldman D, Adolph J, Sama S, Atlas SJ, Carlezon WA, Parsegian A, Lotsch J,
Fillingim RB, Maixner W, Geisslinger G, Max MB, Woolf CJ: GTP
cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and
persistence. Nat Med 2006, 12(11):1269-1277.
12. Walther DJ, Peter JU, Bashammakh S, Hortnagl H, Voits M, Fink H, Bader M:
Synthesis of serotonin by a second tryptophan hydroxylase isoform.
Science 2003, 299(5603):76.
13. Wilson SG, Chesler EJ, Hain H, Rankin AJ, Schwarz JZ, Call SB, Murray MR,
West EE, Teuscher C, Rodriguez-Zas S, Belknap JK, Mogil JS: Identification of
quantitative trait loci for chemical/inflammatory nociception in mice.
Pain 2002, 96(3):385-91.
14. Suzuki R, Rygh LJ, Dickenson AH: Bad news from the brain: descending 5-
HT pathways that control spinal pain processing. Trends Pharmacol Sci
2004, 25(12):613-7.
15. Mhyre TR, Chesler EJ, Thiruchelvam M, Lungu C, Cory-Slechta DA, Fry JD,
Richfield EK: Heritability, correlations and in silico mapping of locomotor
behavior and neurochemistry in inbred strains of mice. Genes Brain Behav
2005, 4(4):209-28.
16. Devoino LB, Al’perina EL, Podgornaya EK, Polyakov OV, Idova GV,
Il’yuchenok RY: Brain content of 5-hydroxytryptamine and 5-
hydroxyindoleacetic acid and immune response in aggressive C57bl/6J
mice. Bull Exp Biol Med 2000, 130(10):954-6.
17. Harvey RJ, Depner UB, Wassle H, Ahmadi S, Heindl C, Reinold H, Smart TG,
Harvey K, Schutz B, Abo-Salem OM, Zimmer A, Poisbeau P, Welzl H,
Wolfer DP, Betz H, Zeilhofer HU, Muller U: GlyR alpha3: an essential target
for spinal PGE2-mediated inflammatory pain sensitization. Science 2004,
304(5672):884-7.
18. Hosl K, Reinold H, Harvey RJ, Muller U, Narumiya S, Zeilhofer HU: Spinal
prostaglandin E receptors of the EP2 subtype and the glycine receptor
alpha3 subunit, which mediate central inflammatory hyperalgesia, do
not contribute to pain after peripheral nerve injury or formalin injection.
Pain 2006, 126(1-3):46-53.
19. Moore KA, Kohno T, Karchewski LA, Scholz J, Baba H, Woolf CJ: Partial
peripheral nerve injury promotes a selective loss of GABAergic inhibition in
the superficial dorsal horn of the spinal cord. J Neurosci 2002, 22(15):6724-31.
20. Hains BC, Everhart AW, Fullwood SD, Hulsebosch CE: Changes in serotonin,
serotonin transporter expression and serotonin denervation
supersensitivity: involvement in chronic central pain after spinal
hemisection in the rat. Exp Neurol 2002, 175(2):347-62.
21. Alhaider AA, Lei SZ, Wilcox GL: Spinal 5-HT3 receptor-mediated
antinociception: possible release of GABA. J Neurosci 1991, 11(7):1881-8.
22. Suzuki R, Morcuende S, Webber M, Hunt SP, Dickenson AH: Superficial
NK1-expressing neurons control spinal excitability through activation of
descending pathways. Nat Neurosci 2002, 5(12):1319-26.
23. Suzuki R, Rahman W, Rygh LJ, Webber M, Hunt SP, Dickenson AH: Spinal-
supraspinal serotonergic circuits regulating neuropathic pain and its
treatment with gabapentin. Pain 2005, 117(3):292-303.
24. Dubuisson D, Dennis SG: The formalin test: a quantitative study of the
analgesic effects of morphine, meperidine, and brain stem stimulation
in rats and cats. Pain 1977, 4(2):161-74.
25. Tjolsen A, Berge OG, Hunskaar S, Rosland JH, Hole K: The formalin test: an
evaluation of the method. Pain 1992, 51(1):5-17.
26. Decosterd I, Woolf CJ: Spared nerve injury: an animal model of persistent
peripheral neuropathic pain. Pain 2000, 87(2):149-58.
27. Bourquin AF, Suveges M, Pertin M, Gilliard N, Sardy S, Davison AC,
Spahn DR, Decosterd I: Assessment and analysis of mechanical allodynia-
like behavior induced by spared nerve injury (SNI) in the mouse. Pain
2006, 122(1-2):14, e1-14.
28. Mogil JS, Wilson SG, Bon K, Lee SE, Chung K, Raber P, Pieper JO, Hain HS,
Belknap JK, Hubert L, Elmer GI, Chung JM, Devor M: Heritability of
nociception II. ‘Types’ of nociception revealed by genetic correlation
analysis. Pain 1999, 80(1-2):83-93.
29. Mogil JS, Wilson SG, Bon K, Lee SE, Chung K, Raber P, Pieper JO, Hain HS,
Belknap JK, Hubert L, Elmer GI, Chung JM, Devor M: Heritability of
nociception I: responses of 11 inbred mouse strains on 12 measures of
nociception. Pain 1999, 80(1-2):67-82.
30. Bon K, Wilson SG, Mogil JS, Roberts WJ: Genetic evidence for the
correlation of deep dorsal horn Fos protein immunoreactivity with tonic
formalin pain behavior. J Pain 2002, 3(3):181-9.
31. Hoover-Plow JL, Gong Y, Shchurin A, Busuttil SJ, Schneeman TA, Hart E:
Strain and model dependent differences in inflammatory cell
recruitment in mice. Inflamm Res 2008, 57(10):457-63.
32. Lopez-Garcia JA, King AE: Pre- and post-synaptic actions of 5-
hydroxytryptamine in the rat lumbar dorsal horn in vitro: implications
for somatosensory transmission. Eur J Neurosci 1996, 8(10):2188-97.
Wijnvoord et al. Molecular Pain 2010, 6:70
http://www.molecularpain.com/content/6/1/70
Page 10 of 11
33. Linhart O, Obreja O, Kress M: The inflammatory mediators serotonin,
prostaglandin E2 and bradykinin evoke calcium influx in rat sensory
neurons. Neuroscience 2003, 118(1):69-74.
34. Okamoto K, Imbe H, Morikawa Y, Itoh M, Sekimoto M, Nemoto K, Senba E:
5-HT2A receptor subtype in the peripheral branch of sensory fibers is
involved in the potentiation of inflammatory pain in rats. Pain 2002,
99(1-2):133-43.
35. Mamet J, Baron A, Lazdunski M, Voilley N: Proinflammatory mediators,
stimulators of sensory neuron excitability via the expression of acid-
sensing ion channels. J Neurosci 2002, 22(24):10662-70.
36. Tokunaga A, Saika M, Senba E: 5-HT2A receptor subtype is involved in the
thermal hyperalgesic mechanism of serotonin in the periphery. Pain
1998, 76(3):349-55.
37. Gold MS, Reichling DB, Shuster MJ, Levine JD: Hyperalgesic agents
increase a tetrodotoxin-resistant Na+ current in nociceptors. Proc Natl
Acad Sci USA 1996, 93(3):1108-12.
38. Braz JM, Basbaum AI: Genetically expressed transneuronal tracer reveals
direct and indirect serotonergic descending control circuits. J Comp
Neurol 2008, 507(6):1990-2003.
39. Braz JM, Enquist LW, Basbaum AI: Inputs to serotonergic neurons revealed
by conditional viral transneuronal tracing. J Comp Neurol 2009,
514(2):145-60.
40. Tapocik JD, Letwin N, Mayo CL, Frank B, Luu T, Achinike O, House C,
Williams R, Elmer GI, Lee NH: Identification of candidate genes and gene
networks specifically associated with analgesic tolerance to morphine. J
Neurosci 2009, 29(16):5295-307.
41. Cervo L, Canetta A, Calcagno E, Burbassi S, Sacchetti G, Caccia S, Fracasso C,
Albani D, Forloni G, Invernizzi RW: Genotype-dependent activity of
tryptophan hydroxylase-2 determines the response to citalopram in a
mouse model of depression. J Neurosci 2005, 25(36):8165-72.
42. Zhang X, Beaulieu JM, Sotnikova TD, Gainetdinov RR, Caron MG:
Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science
2004, 305(5681):217.
43. Tenner K, Qadri F, Bert B, Voigt JP, Bader M: The mTPH2 C1473G single
nucleotide polymorphism is not responsible for behavioural differences
between mouse strains. Neurosci Lett 2008, 431(1):21-5.
44. Carneiro AM, Airey DC, Thompson B, Zhu CB, Lu L, Chesler EJ, Erikson KM,
Blakely RD: Functional coding variation in recombinant inbred mouse
lines reveals multiple serotonin transporter-associated phenotypes. Proc
Natl Acad Sci USA 2009, 106(6):2047-52.
45. Berrocoso E, Rojas-Corrales MO, Mico JA: Differential role of 5-HT1A and 5-
HT1B receptors on the antinociceptive and antidepressant effect of
tramadol in mice. Psychopharmacology (Berl) 2006, 188(1):111-8.
46. Suzuki R, Rahman W, Hunt SP, Dickenson AH: Descending facilitatory
control of mechanically evoked responses is enhanced in deep dorsal
horn neurones following peripheral nerve injury. Brain Res 2004, 1019(1-
2):68-76.
47. Xiao DQ, Zhu JX, Tang JS, Jia H: 5-hydroxytryptamine 1A (5-HT1A) but not
5-HT3 receptor is involved in mediating the nucleus submedius 5-HT-
evoked antinociception in the rat. Brain Res 2005, 1046(1-2):38-44.
48. Lanoir J, Hilaire G, Seif I: Reduced density of functional 5-HT1A receptors
in the brain, medulla and spinal cord of monoamine oxidase-A
knockout mouse neonates. J Comp Neurol 2006, 495(5):607-23.
doi:10.1186/1744-8069-6-70
Cite this article as: Wijnvoord et al.: Inter-strain differences of
serotonergic inhibitory pain control in inbred mice. Molecular Pain 2010
6:70.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Wijnvoord et al. Molecular Pain 2010, 6:70
http://www.molecularpain.com/content/6/1/70
Page 11 of 11
